Blinatumomab in Acute Lymphoblastic Leukemia
1 Ansichten
• 06/15/23
0
0
Einbetten
administrator
Abonnenten
In this segment, Dan Douer, MD, and Mark R Litzow, MD, describe the novel immunotherapy agent, blinatumomab.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare